Pierre Boulud

Chief Executive Officer, Biomérieux

Search every verified Pierre Boulud interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Pierre Boulud, deputy CEO of bioMérieux, discussed the company's 2020 financial results in a March 2021 interview, noting that the company exceeded 3 billion euros in revenue for the first time and reported net profit above 400 million euros. He attributed the performance to the demand for COVID-19 tests and said the company's 12,800 employees mobilized to produce a full range of anti-COVID tests at its factories in France and the United States. Boulud stated that bioMérieux allocated 42 million euros to solidarity initiatives, including donations to the Mérieux Foundation and to "L'entreprise des possibles," a collective of companies initiated by Alain Mérieux. He described 2020 as an exceptional year and said the company guided for 5 to 8 percent sales growth in 2021, while acknowledging uncertainty due to the evolving pandemic. In a July 2021 interview, Boulud reported that bioMérieux had strong first-half results with sales growth of over 15 percent. He said the company did not provide full-year forecasts because the impact of the COVID-19 epidemic varied by country and continent, making it difficult to anticipate future developments. Boulud emphasized that bioMérieux's headquarters and a significant portion of its manufacturing and R&D activities remain in Lyon, France, and that the company is focused on its societal and environmental impact, an area CEO Alexandre Mérieux has prioritized.